Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

1/9/2008 Pediatric Deferral Email - RECOTHROM

From: Jain, Nisha

Sent: Wednesday, January 09, 2008 12:10 PM

To: 'MAGU (Mark Gauthier)'

Cc: Drews, Roman T; Shields, Mark

Subject: RE: Pediatric Deferral

Hi Mark,

As communicated to you during our telephone conversation, please submit the following:

expand age group to include newborns
provide scientific rationale to support extrapolation of efficacy from adults


From: MAGU (Mark Gauthier) []

Sent: Tuesday, January 08, 2008 8:19 PM

To: Jain, Nisha

Subject: Pediatric Deferral

Hi Nisha,

I forgot to ask what time the Pediatric Subcommittee meeting is taking place. Would you send me an email note after the meeting and let me know what the outcome is either way? That way I will know if this is resolved based on what we already submitted (ideal) or if we need to send you the synopsis that will be finalized tomorrow.

Thank you,


Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 08/10/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English